Publications

Detailed Information

Burden and future projection of revision Total hip Arthroplasty in South Korea

DC Field Value Language
dc.contributor.authorPark, Jung-Wee-
dc.contributor.authorWon, Seok-Hyung-
dc.contributor.authorMoon, Sun-Young-
dc.contributor.authorLee, Young-Kyun-
dc.contributor.authorHa, Yong-Chan-
dc.contributor.authorKoo, Kyung-Hoi-
dc.date.accessioned2021-07-12T01:12:02Z-
dc.date.available2021-07-12T10:13:25Z-
dc.date.issued2021-04-22-
dc.identifier.citationBMC Musculoskeletal Disorders. 2021 Apr 22;22(1):375ko_KR
dc.identifier.issn1471-2474-
dc.identifier.urihttps://hdl.handle.net/10371/174681-
dc.description.abstractBackground
The annual number of hip arthroplasties is increasing combined with the aging population worldwide. In accordance with the increasing number of primary hip arthroplasties, the number of revision total hip arthroplasties (THAs) is expected to increase. The incidence and burden of revision THAs in the United States and have been reported by registry studies. To identify potential differences according to ethnics and regional practice, it is important to obtain data from East Asia. Nevertheless, there has been a lack of studies on the burden and future projection of revision THA based on a large-scale database in East Asia. The purpose of this study was to evaluate annual incidence and burden of revision THAs and to project the future burden in South Korea.

Methods
We identified primary THAs, primary hemiarthroplasties (HAs) and revision THAs, which were performed from 2010 to 2018, using database of Health Insurance and Review and Assessment (HIRA); nation-wide medical claim system of South Korea. The annual incidence rates (per 100,000) of primary THA, primary HA and revision THA, and the annual burden of revision THA; the number of revision THAs divided by the sum of primary hip arthroplasties and revision THAs, were calculated. The future burden of revision THAs were projected through 2030 using generalized linear model with Quasi-poisson regression.

Results
During the 9-year period, the annual incidences of primary THA, primary HA and revision THA increased by 47, 29 and 3%, respectively, while the revision burden decreased from 0.13 to 0.10. Compared to 2018, the annual incidences of primary THA, HA, and revision THA were projected to increase by 7.2, 2.3 and 1.1% per year, respectively, whereas the burden of revision THA was projected to decrease to 0.07 in 2030.

Conclusion
Trends of revision THA in South Korea were similar with those of national registry studies from the United States. The annual incidence of revision THA has steadily increased, whereas its burden has decreased. Findings of our study could be used for epidemiological comparison between Western countries and East Asia as well as for the establishment of medical policies of revision THA in East Asian countries.
ko_KR
dc.description.sponsorshipThis study was funded by a grant of the Korea Health Technology R&D funded by the Ministry of Health & Welfare, Republic of Korea [grant number: HI18C0284]. The role of the funding by grant was in the access to and the analysis of the database.ko_KR
dc.language.isoenko_KR
dc.publisherBMCko_KR
dc.subjectHip-
dc.subjectArthroplasty-
dc.subjectRevision-
dc.subjectBurden-
dc.subjectEast Asia-
dc.subjectSouth Korea-
dc.titleBurden and future projection of revision Total hip Arthroplasty in South Koreako_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor박정위-
dc.contributor.AlternativeAuthor원석형-
dc.contributor.AlternativeAuthor문선영-
dc.contributor.AlternativeAuthor이영균-
dc.contributor.AlternativeAuthor하용찬-
dc.contributor.AlternativeAuthor구경회-
dc.identifier.doi10.1186/s12891-021-04235-3-
dc.citation.journaltitleBMC Musculoskeletal Disordersko_KR
dc.language.rfc3066en-
dc.rights.holderThe Author(s)-
dc.date.updated2021-04-25T03:19:28Z-
dc.citation.number1ko_KR
dc.citation.startpage375ko_KR
dc.citation.volume22ko_KR
Appears in Collections:
Files in This Item:

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share